Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Key takeaways Ozempic (semaglutide) and Trulicity (dulaglutide) are FDA-approved GLP-1 receptor agonists used for Type 2 diabetes and cardiovascular risk reduction
It has been suggested that these differences between compounds may also be reflected in their cardiovascular effects [44]
Anyone with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not take GLP 1 medications
Novo Nordisks blockbuster molecule, semaglutide, was launched for Type 2 diabetes (T2D) in 2018 as Ozempic
Doing the math
US$ 28.13
US$ 21.05
US$ 22.26
US$ 22.43
US$ 21.92
